Pablo Riedemann

460 total citations
10 papers, 223 citations indexed

About

Pablo Riedemann is a scholar working on Rheumatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pablo Riedemann has authored 10 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 2 papers in Surgery and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pablo Riedemann's work include Rheumatoid Arthritis Research and Therapies (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Pablo Riedemann is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Pablo Riedemann collaborates with scholars based in Chile, Canada and United Kingdom. Pablo Riedemann's co-authors include Peter Tugwell, Xabier de Aretxabala, Juan Carlos Roa, Kazuo Endoh, Miguel Villaseca, Iván Roa, M H Cardiel, Kathryn Bennett, Marcos Bosi Ferraz and Charlie H. Goldsmith and has published in prestigious journals such as Gastroenterology, Annals of the Rheumatic Diseases and The Journal of Rheumatology.

In The Last Decade

Pablo Riedemann

10 papers receiving 216 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Riedemann Chile 7 96 85 56 33 30 10 223
Malgorzata Magliano United Kingdom 5 34 0.4× 34 0.4× 48 0.9× 36 1.1× 20 0.7× 10 220
Hui Song China 9 28 0.3× 32 0.4× 78 1.4× 19 0.6× 12 0.4× 29 202
Zheng‐Ju Ren China 10 52 0.5× 67 0.8× 45 0.8× 7 0.2× 10 0.3× 38 289
S. Foley United Kingdom 8 137 1.4× 97 1.1× 68 1.2× 37 1.1× 3 0.1× 12 323
Steven M. Fink United States 9 219 2.3× 23 0.3× 43 0.8× 15 0.5× 11 0.4× 9 373
C. M. Hau United Kingdom 8 170 1.8× 69 0.8× 27 0.5× 17 0.5× 4 0.1× 10 294
Daniele Urzì Italy 10 57 0.6× 98 1.2× 52 0.9× 2 0.1× 24 0.8× 17 266
Mahmut Özdemir Türkiye 9 39 0.4× 20 0.2× 29 0.5× 14 0.4× 6 0.2× 28 312
L. Ichchou Morocco 8 75 0.8× 13 0.2× 73 1.3× 11 0.3× 11 0.4× 43 295
Yun-Tao Zhao China 8 33 0.3× 17 0.2× 16 0.3× 24 0.7× 7 0.2× 42 246

Countries citing papers authored by Pablo Riedemann

Since Specialization
Citations

This map shows the geographic impact of Pablo Riedemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Riedemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Riedemann more than expected).

Fields of papers citing papers by Pablo Riedemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Riedemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Riedemann. The network helps show where Pablo Riedemann may publish in the future.

Co-authorship network of co-authors of Pablo Riedemann

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Riedemann. A scholar is included among the top collaborators of Pablo Riedemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Riedemann. Pablo Riedemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Massardo, Loreto, Carolina Llanos, Paula I. Burgos, et al.. (2019). SAT0608 THE PREVALENCE OF RHEUMATOID ARTHRITIS IN CHILE, A STUDY PERFORMED AS PART OF THE NATIONAL SURVEY HEALTH (ENS 2016-17). Annals of the Rheumatic Diseases. 78. 1398–1399. 2 indexed citations
2.
Massardo, Loreto, Carolina Llanos, Paula I. Burgos, et al.. (2019). The Prevalence of Rheumatoid Arthritis in Chile: A Nationwide Study Performed as Part of the National Health Survey. The Journal of Rheumatology. 47(7). 951–958. 8 indexed citations
3.
Alarcón, Ana María, et al.. (2014). Contribution of ethnic group and socioeconomic status to degree of disability in rheumatoid arthritis in Chilean patients. Rheumatology International. 35(4). 685–689. 10 indexed citations
4.
Serón, Pamela, et al.. (2005). Effect of Inspiratory Muscle Training on Muscle Strength and Quality of Life in Patients With Chronic Airflow Limitation: a Randomized Controlled Trial. Archivos de Bronconeumología. 41(11). 601–606. 17 indexed citations
6.
Riedemann, Pablo. (2004). Epidemiología de las afecciones reumatológicas del adulto mayor. Medwave. 4(8). 1 indexed citations
7.
Bennett, Kathryn, M H Cardiel, Marcos Bosi Ferraz, et al.. (1997). Community screening for rheumatic disorder: cross cultural adaptation and screening characteristics of the COPCORD Core Questionnaire in Brazil, Chile, and Mexico. The PANLAR-COPCORD Working Group. Pan American League of Associations for Rheumatology. Community Oriented Programme for the Control of Rheumatic Disease.. PubMed. 24(1). 160–8. 63 indexed citations
8.
Roa, Iván, Miguel Villaseca, Xabier de Aretxabala, et al.. (1996). Preneoplastic lesions and gallbladder cancer: An estimate of the period required for progression. Gastroenterology. 111(1). 232–236. 92 indexed citations
9.
Riedemann, Pablo, et al.. (1993). A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: a meta-analysis.. PubMed. 20(12). 2095–103. 17 indexed citations
10.
Llanos, Carolina, et al.. (1992). [Anticardiolipin antibodies in rheumatic autoimmune diseases. Correlation with clinical and laboratory findings].. PubMed. 120(11). 1235–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026